[ad_1] SCHLIEREN, Switzerland, October 09, 2023–(BUSINESS WIRE)–LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA…